Pain represents one of the most prevalent clinical symptoms affecting human health and quality of life worldwide. Conventional analgesic drugs such as opioids and non-steroidal anti-inflammatory drugs (NSAIDs) are associated with significant adverse effects, including gastrointestinal irritation, tolerance, dependence, and organ toxicity. Consequently, medicinal plants have gained increasing scientific attention as alternative sources of safer analgesic agents. Natural phytochemicals such as flavonoids, alkaloids, terpenoids, phenolic acids, saponins, and glycosides demonstrate significant antinociceptive and anti-inflammatory properties through modulation of nociceptive signaling pathways, oxidative stress and neuroinflammatory responses. This systematic review compiles experimental and mechanistic evidence regarding analgesic medicinal plants evaluated in in-vitro and in vivo models, including hot plate test, tail flick test, acetic acid-induced writhing, formalin test and carrageenan-induced inflammation. Molecular targets such as cyclooxygenase enzymes, transient receptor potential channels, cytokines, ion channels and glial activation pathways are discussed. Despite promising preclinical findings, challenges remain in extract standardization, pharmacokinetic evaluation, and controlled clinical trials. Advances in phytochemical characterization, nanotechnology-based drug delivery, and translational pharmacology may facilitate development of plant-derived analgesic therapeutics. Natural analgesics hold substantial potential for future drug discovery and integrative pain management strategies.
Shiv Kumar Bhardwaj2* Parwati Chouhan1 (Sun,) studied this question.